Literature DB >> 23356439

Perturbations of Plasmodium Puf2 expression and RNA-seq of Puf2-deficient sporozoites reveal a critical role in maintaining RNA homeostasis and parasite transmissibility.

Scott E Lindner1, Sebastian A Mikolajczak, Ashley M Vaughan, Wonjong Moon, Brad R Joyce, William J Sullivan, Stefan H I Kappe.   

Abstract

Malaria's cycle of infection requires parasite transmission between a mosquito vector and a mammalian host. We here demonstrate that the Plasmodium yoelii Pumilio-FBF family member Puf2 allows the sporozoite to remain infectious in the mosquito salivary glands while awaiting transmission. Puf2 mediates this solely through its RNA-binding domain (RBD) likely by stabilizing or hastening the degradation of specific mRNAs. Puf2 traffics to sporozoite cytosolic granules, which are negative for several markers of stress granules and P-bodies, and disappear rapidly after infection of hepatocytes. In contrast to previously described Plasmodium berghei pbpuf2(-) parasites, pypuf2(-) sporozoites have no apparent defect in host infection when tested early in salivary gland residence, but become progressively non-infectious and prematurely transform into EEFs during prolonged salivary gland residence. The premature overexpression of Puf2 in oocysts causes striking deregulation of sporozoite maturation and infectivity while extension of Puf2 expression in liverstages causes no defect, suggesting that the presence of Puf2 alone is not sufficient for its functions. Finally, by conducting the first comparative RNA-seq analysis of Plasmodium sporozoites, we find that Puf2 may play a role in directly or indirectly maintaining the homeostasis of specific transcripts. These findings uncover requirements for maintaining a window of opportunity for the malaria parasite to accommodate the unpredictable moment of transmission from mosquito to mammalian host.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23356439      PMCID: PMC3815636          DOI: 10.1111/cmi.12116

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  57 in total

1.  Development of infectivity by the Plasmodium berghei sporozoite.

Authors:  J P Vanderberg
Journal:  J Parasitol       Date:  1975-02       Impact factor: 1.276

2.  Studies on malarial sporozoites. II. Effect of age and dosage of sporozoites on their infectiousness.

Authors:  R J PORTER; R L LAIRD; E M DUSSEAU
Journal:  Exp Parasitol       Date:  1954-05       Impact factor: 2.011

3.  Parasite-specific eIF2 (eukaryotic initiation factor-2) kinase required for stress-induced translation control.

Authors:  William J Sullivan; Jana Narasimhan; Micah M Bhatti; Ronald C Wek
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

4.  Column separation of Plasmodium berghei sporozoites.

Authors:  S R Mack; J P Vanderberg; R Nawrot
Journal:  J Parasitol       Date:  1978-02       Impact factor: 1.276

5.  Infectivity-associated changes in the transcriptional repertoire of the malaria parasite sporozoite stage.

Authors:  Kai Matuschewski; Jessica Ross; Stuart M Brown; Karine Kaiser; Victor Nussenzweig; Stefan H I Kappe
Journal:  J Biol Chem       Date:  2002-08-12       Impact factor: 5.157

6.  Structure and expression of a post-transcriptionally regulated malaria gene encoding a surface protein from the sexual stages of Plasmodium berghei.

Authors:  M G Paton; G C Barker; H Matsuoka; J Ramesar; C J Janse; A P Waters; R E Sinden
Journal:  Mol Biochem Parasitol       Date:  1993-06       Impact factor: 1.759

7.  Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii.

Authors:  Jane M Carlton; Samuel V Angiuoli; Bernard B Suh; Taco W Kooij; Mihaela Pertea; Joana C Silva; Maria D Ermolaeva; Jonathan E Allen; Jeremy D Selengut; Hean L Koo; Jeremy D Peterson; Mihai Pop; Daniel S Kosack; Martin F Shumway; Shelby L Bidwell; Shamira J Shallom; Susan E van Aken; Steven B Riedmuller; Tamara V Feldblyum; Jennifer K Cho; John Quackenbush; Martha Sedegah; Azadeh Shoaibi; Leda M Cummings; Laurence Florens; John R Yates; J Dale Raine; Robert E Sinden; Michael A Harris; Deirdre A Cunningham; Peter R Preiser; Lawrence W Bergman; Akhil B Vaidya; Leo H van Lin; Chris J Janse; Andrew P Waters; Hamilton O Smith; Owen R White; Steven L Salzberg; J Craig Venter; Claire M Fraser; Stephen L Hoffman; Malcolm J Gardner; Daniel J Carucci
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

8.  Proteasome inhibitors block development of Plasmodium spp.

Authors:  S M Gantt; J M Myung; M R Briones; W D Li; E J Corey; S Omura; V Nussenzweig; P Sinnis
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

9.  Transformation of sporozoites into early exoerythrocytic malaria parasites does not require host cells.

Authors:  Karine Kaiser; Nelly Camargo; Stefan H I Kappe
Journal:  J Exp Med       Date:  2003-04-21       Impact factor: 14.307

10.  Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle.

Authors:  Karine G Le Roch; Jeffrey R Johnson; Laurence Florens; Yingyao Zhou; Andrey Santrosyan; Munira Grainger; S Frank Yan; Kim C Williamson; Anthony A Holder; Daniel J Carucci; John R Yates; Elizabeth A Winzeler
Journal:  Genome Res       Date:  2004-11       Impact factor: 9.043

View more
  41 in total

Review 1.  Sexual development in Plasmodium parasites: knowing when it's time to commit.

Authors:  Gabrielle A Josling; Manuel Llinás
Journal:  Nat Rev Microbiol       Date:  2015-09       Impact factor: 60.633

Review 2.  Plasmodium Sporozoite Biology.

Authors:  Friedrich Frischknecht; Kai Matuschewski
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

3.  Th1-like Plasmodium-Specific Memory CD4+ T Cells Support Humoral Immunity.

Authors:  Ryan A Zander; Rahul Vijay; Angela D Pack; Jenna J Guthmiller; Amy C Graham; Scott E Lindner; Ashley M Vaughan; Stefan H I Kappe; Noah S Butler
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

Review 4.  Translational Control in the Latency of Apicomplexan Parasites.

Authors:  Michael J Holmes; Leonardo da Silva Augusto; Min Zhang; Ronald C Wek; William J Sullivan
Journal:  Trends Parasitol       Date:  2017-09-20

5.  Enzymes involved in plastid-targeted phosphatidic acid synthesis are essential for Plasmodium yoelii liver-stage development.

Authors:  Scott E Lindner; Mark J Sartain; Kiera Hayes; Anke Harupa; Robert L Moritz; Stefan H I Kappe; Ashley M Vaughan
Journal:  Mol Microbiol       Date:  2014-01-07       Impact factor: 3.501

6.  ALBA4 modulates its stage-specific interactions and specific mRNA fates during Plasmodium yoelii growth and transmission.

Authors:  Elyse E Muñoz; Kevin J Hart; Michael P Walker; Mark F Kennedy; Mackenzie M Shipley; Scott E Lindner
Journal:  Mol Microbiol       Date:  2017-08-29       Impact factor: 3.501

Review 7.  RNA-binding proteins related to stress response and differentiation in protozoa.

Authors:  Lysangela Ronalte Alves; Samuel Goldenberg
Journal:  World J Biol Chem       Date:  2016-02-26

8.  Ribozyme-mediated, multiplex CRISPR gene editing and CRISPR interference (CRISPRi) in rodent-infectious Plasmodium yoelii.

Authors:  Michael P Walker; Scott E Lindner
Journal:  J Biol Chem       Date:  2019-05-01       Impact factor: 5.157

Review 9.  Transcript maturation in apicomplexan parasites.

Authors:  Elena S Suvorova; Michael W White
Journal:  Curr Opin Microbiol       Date:  2014-06-14       Impact factor: 7.934

10.  Type II fatty acid biosynthesis is essential for Plasmodium falciparum sporozoite development in the midgut of Anopheles mosquitoes.

Authors:  Ben C L van Schaijk; T R Santha Kumar; Martijn W Vos; Adam Richman; Geert-Jan van Gemert; Tao Li; Abraham G Eappen; Kim C Williamson; Belinda J Morahan; Matt Fishbaugher; Mark Kennedy; Nelly Camargo; Shahid M Khan; Chris J Janse; Kim Lee Sim; Stephen L Hoffman; Stefan H I Kappe; Robert W Sauerwein; David A Fidock; Ashley M Vaughan
Journal:  Eukaryot Cell       Date:  2013-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.